About FDA
Percent of FDA advisory committee member positions vacant at the end of the month
Dictionary: Access to state-of-the-art, scientific expert advice to support agency decision making processes is imperative to the FDA advisory committee process. Having the fewest vacancies on our committees allows the agency to have ready access to those experts and supports the ability of FDA to meet its public health mission. For more information about FDA advisory committees, please visit http://www.fda.gov/AdvisoryCommittees/default.htm
Information is current as September 30, 2021.
Fiscal Year - 2021
| Time | Target | Percent Vacant Positions |
|---|---|---|
| Oct 2020 | 10 | 16 |
| Nov 2020 | 10 | 18 |
| Dec 2020 | 10 | 17 |
| Jan 2021 | 10 | 17 |
| Feb 2021 | 10 | 20 |
| Mar 2021 | 10 | 18 |
| Apr 2021 | 10 | 20 |
| May 2021 | 10 | 20 |
| Jun 2021 | 10 | 21 |
| Jul 2021 | 10 | 22 |
| Aug 2021 | 10 | 23 |
| Sep 2021 | 10 | 21 |
FY 2021 Total: 21%
Number of FDA advisory committee member positions vacant at the end of the month
Fiscal Year - 2021
| Time | Target | Vacant Positions |
|---|---|---|
| Oct 2020 | N/A | 88 |
| Nov 2020 | N/A | 98 |
| Dec 2020 | N/A | 89 |
| Jan 2021 | N/A | 91 |
| Feb 2021 | N/A | 104 |
| Mar 2021 | N/A | 96 |
| Apr 2021 | N/A | 104 |
| May 2021 | N/A | 104 |
| Jun 2021 | N/A | 110 |
| Jul 2021 | N/A | 115 |
| Aug 2021 | N/A | 121 |
| Sep 2021 | N/A | 114 |
FY 2021 Total: 114
Total number of FDA advisory committee member positions at the end of the month
Fiscal Year - 2021
| Time | Target | Positions |
|---|---|---|
| Oct 2020 | N/A | 547 |
| Nov 2020 | N/A | 547 |
| Dec 2020 | N/A | 547 |
| Jan 2021 | N/A | 532 |
| Feb 2021 | N/A | 532 |
| Mar 2021 | N/A | 532 |
| Apr 2021 | N/A | 532 |
| May 2021 | N/A | 532 |
| Jun 2021 | N/A | 532 |
| Jul 2021 | N/A | 532 |
| Aug 2021 | N/A | 532 |
| Sep 2021 | N/A | 532 |
FY 2021 Total: 532
Footnotes
- CVM's Advisory Committee was terminated on September 30, 2013.
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.
